Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Falsely Elevated Vancomycin Concentrations in a Patient Not Receiving Vancomycin.

Tsoi V, Bhayana V, Bombassaro AM, Tirona RG, Kittanakom S.

Pharmacotherapy. 2019 May 11. doi: 10.1002/phar.2279. [Epub ahead of print]

PMID:
31077424
2.

Pre-analytical variables affecting discordant results on repeat sample testing for cardiac troponin I.

Kittanakom S, Ly V, Arnoldo A, Beattie A, Kavsak PA.

Clin Biochem. 2019 Jan;63:158-160. doi: 10.1016/j.clinbiochem.2018.10.014. Epub 2018 Oct 28. No abstract available.

PMID:
30393000
3.

The importance of tumour marker dual reporting during method transition: PSA high-dose hook effect detected.

Kittanakom S, Donohue V, Beattie J, Clark L, Kavsak PA.

Clin Biochem. 2018 Nov;61:45-46. doi: 10.1016/j.clinbiochem.2018.08.011. Epub 2018 Sep 1. No abstract available.

PMID:
30179593
4.

Differences in total PSA results within and between manufacturers.

Kittanakom S, Clark L, Roy C, Malinowski P, Bamford K, Lamers S, Kavsak PA.

Clin Biochem. 2018 Sep;60:91-92. doi: 10.1016/j.clinbiochem.2018.07.009. Epub 2018 Jul 20. No abstract available.

PMID:
30036511
5.

Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease.

Kittanakom S, Shajib MS, Garvie K, Turner J, Brooks D, Odeh S, Issenman R, Chetty VT, Macri J, Khan WI.

Can J Gastroenterol Hepatol. 2017;2017:1450970. doi: 10.1155/2017/1450970. Epub 2017 Apr 16.

6.

Systematic protein-protein interaction mapping for clinically relevant human GPCRs.

Sokolina K, Kittanakom S, Snider J, Kotlyar M, Maurice P, Gandía J, Benleulmi-Chaachoua A, Tadagaki K, Oishi A, Wong V, Malty RH, Deineko V, Aoki H, Amin S, Yao Z, Morató X, Otasek D, Kobayashi H, Menendez J, Auerbach D, Angers S, Pržulj N, Bouvier M, Babu M, Ciruela F, Jockers R, Jurisica I, Stagljar I.

Mol Syst Biol. 2017 Mar 15;13(3):918. doi: 10.15252/msb.20167430.

7.

Metrics for identifying errors related to pre-analytical sample handling.

Kittanakom S, Kavsak PA.

Clin Biochem. 2014 Aug;47(12):989-90. doi: 10.1016/j.clinbiochem.2014.07.001. Epub 2014 Jul 11. No abstract available.

PMID:
25017973
8.

A genome scale overexpression screen to reveal drug activity in human cells.

Arnoldo A, Kittanakom S, Heisler LE, Mak AB, Shukalyuk AI, Torti D, Moffat J, Giaever G, Nislow C.

Genome Med. 2014 Apr 29;6(4):32. doi: 10.1186/gm549. eCollection 2014.

9.

CHIP-MYTH: a novel interactive proteomics method for the assessment of agonist-dependent interactions of the human β₂-adrenergic receptor.

Kittanakom S, Barrios-Rodiles M, Petschnigg J, Arnoldo A, Wong V, Kotlyar M, Heisler LE, Jurisica I, Wrana JL, Nislow C, Stagljar I.

Biochem Biophys Res Commun. 2014 Mar 21;445(4):746-56. doi: 10.1016/j.bbrc.2014.02.033. Epub 2014 Feb 19.

PMID:
24561123
10.

The identification of novel proteins that interact with the GLP-1 receptor and restrain its activity.

Huang X, Dai FF, Gaisano G, Giglou K, Han J, Zhang M, Kittanakom S, Wong V, Wei L, Showalter AD, Sloop KW, Stagljar I, Wheeler MB.

Mol Endocrinol. 2013 Sep;27(9):1550-63. doi: 10.1210/me.2013-1047. Epub 2013 Jul 17.

11.

Aerosolized liposomal Amphotericin B: a potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients.

Kamalaporn H, Leung K, Nagel M, Kittanakom S, Calvieri B, Reithmeier RA, Coates AL.

Pediatr Pulmonol. 2014 Jun;49(6):574-80. doi: 10.1002/ppul.22856. Epub 2013 Jul 10.

PMID:
23843366
12.

MOR is not enough: identification of novel mu-opioid receptor interacting proteins using traditional and modified membrane yeast two-hybrid screens.

Petko J, Justice-Bitner S, Jin J, Wong V, Kittanakom S, Ferraro TN, Stagljar I, Levenson R.

PLoS One. 2013 Jun 28;8(6):e67608. doi: 10.1371/journal.pone.0067608. Print 2013.

13.

Miniature short hairpin RNA screens to characterize antiproliferative drugs.

Kittanakom S, Arnoldo A, Brown KR, Wallace I, Kunavisarut T, Torti D, Heisler LE, Surendra A, Moffat J, Giaever G, Nislow C.

G3 (Bethesda). 2013 Aug 7;3(8):1375-87. doi: 10.1534/g3.113.006437.

14.

Regulation of CD133 by HDAC6 promotes β-catenin signaling to suppress cancer cell differentiation.

Mak AB, Nixon AM, Kittanakom S, Stewart JM, Chen GI, Curak J, Gingras AC, Mazitschek R, Neel BG, Stagljar I, Moffat J.

Cell Rep. 2012 Oct 25;2(4):951-63. doi: 10.1016/j.celrep.2012.09.016. Epub 2012 Oct 19.

15.

Barcode sequencing for understanding drug-gene interactions.

Smith AM, Durbic T, Kittanakom S, Giaever G, Nislow C.

Methods Mol Biol. 2012;910:55-69. doi: 10.1007/978-1-61779-965-5_4.

PMID:
22821592
16.

Detecting interactions with membrane proteins using a membrane two-hybrid assay in yeast.

Snider J, Kittanakom S, Damjanovic D, Curak J, Wong V, Stagljar I.

Nat Protoc. 2010 Jul;5(7):1281-93. doi: 10.1038/nprot.2010.83. Epub 2010 Jun 17.

PMID:
20595957
17.

Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependence.

Jin J, Kittanakom S, Wong V, Reyes BA, Van Bockstaele EJ, Stagljar I, Berrettini W, Levenson R.

BMC Neurosci. 2010 Mar 9;11:33. doi: 10.1186/1471-2202-11-33.

18.

Split-ubiquitin based membrane yeast two-hybrid (MYTH) system: a powerful tool for identifying protein-protein interactions.

Snider J, Kittanakom S, Curak J, Stagljar I.

J Vis Exp. 2010 Feb 1;(36). pii: 1698. doi: 10.3791/1698.

19.

Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6.

Deribe YL, Wild P, Chandrashaker A, Curak J, Schmidt MHH, Kalaidzidis Y, Milutinovic N, Kratchmarova I, Buerkle L, Fetchko MJ, Schmidt P, Kittanakom S, Brown KR, Jurisica I, Blagoev B, Zerial M, Stagljar I, Dikic I.

Sci Signal. 2009 Dec 22;2(102):ra84. doi: 10.1126/scisignal.2000576.

PMID:
20029029
20.

Analysis of membrane protein complexes using the split-ubiquitin membrane yeast two-hybrid (MYTH) system.

Kittanakom S, Chuk M, Wong V, Snyder J, Edmonds D, Lydakis A, Zhang Z, Auerbach D, Stagljar I.

Methods Mol Biol. 2009;548:247-71. doi: 10.1007/978-1-59745-540-4_14.

PMID:
19521829
21.

Two-hybrid technologies in proteomics research.

Suter B, Kittanakom S, Stagljar I.

Curr Opin Biotechnol. 2008 Aug;19(4):316-23. doi: 10.1016/j.copbio.2008.06.005. Epub 2008 Jul 23. Review.

PMID:
18619540
22.

Interactive proteomics: what lies ahead?

Suter B, Kittanakom S, Stagljar I.

Biotechniques. 2008 Apr;44(5):681-91. doi: 10.2144/000112799. Review.

23.

Identification of small molecule inhibitors of Pseudomonas aeruginosa exoenzyme S using a yeast phenotypic screen.

Arnoldo A, Curak J, Kittanakom S, Chevelev I, Lee VT, Sahebol-Amri M, Koscik B, Ljuma L, Roy PJ, Bedalov A, Giaever G, Nislow C, Merrill AR, Lory S, Stagljar I.

PLoS Genet. 2008 Feb 29;4(2):e1000005. doi: 10.1371/journal.pgen.1000005. Erratum in: PLoS Genet. 2008 Apr;4(4). doi: 10.1371/annotation/76d35829-07a2-479f-bbc1-cce6755b6d8c. Merrill, Rod A [corrected to Merrill, A Rod].

24.

Monitoring protein-protein interactions between the mammalian integral membrane transporters and PDZ-interacting partners using a modified split-ubiquitin membrane yeast two-hybrid system.

Gisler SM, Kittanakom S, Fuster D, Wong V, Bertic M, Radanovic T, Hall RA, Murer H, Biber J, Markovich D, Moe OW, Stagljar I.

Mol Cell Proteomics. 2008 Jul;7(7):1362-77. doi: 10.1074/mcp.M800079-MCP200. Epub 2008 Apr 11.

25.
26.

Interaction of integrin-linked kinase with the kidney chloride/bicarbonate exchanger, kAE1.

Keskanokwong T, Shandro HJ, Johnson DE, Kittanakom S, Vilas GL, Thorner P, Reithmeier RA, Akkarapatumwong V, Yenchitsomanus PT, Casey JR.

J Biol Chem. 2007 Aug 10;282(32):23205-18. Epub 2007 Jun 6.

27.

Dominant and recessive distal renal tubular acidosis mutations of kidney anion exchanger 1 induce distinct trafficking defects in MDCK cells.

Cordat E, Kittanakom S, Yenchitsomanus PT, Li J, Du K, Lukacs GL, Reithmeier RA.

Traffic. 2006 Feb;7(2):117-28.

28.

Human kanadaptin and kidney anion exchanger 1 (kAE1) do not interact in transfected HEK 293 cells.

Kittanakom S, Keskanokwong T, Akkarapatumwong V, Yenchitsomanus PT, Reithmeier RA.

Mol Membr Biol. 2004 Nov-Dec;21(6):395-402.

PMID:
15764369
29.

Molecular mechanisms of autosomal dominant and recessive distal renal tubular acidosis caused by SLC4A1 (AE1) mutations.

Yenchitsomanus PT, Kittanakom S, Rungroj N, Cordat E, Reithmeier RA.

J Mol Genet Med. 2005 Nov 16;1(2):49-62.

30.

Trafficking defects of a novel autosomal recessive distal renal tubular acidosis mutant (S773P) of the human kidney anion exchanger (kAE1).

Kittanakom S, Cordat E, Akkarapatumwong V, Yenchitsomanus PT, Reithmeier RA.

J Biol Chem. 2004 Sep 24;279(39):40960-71. Epub 2004 Jul 13.

Supplemental Content

Loading ...
Support Center